CAR-T-Therapie

CAR-T therapy engineers T cells to attack cancer; focus on auto/allo and targets.The sector's total market cap is 1554.28 billion USD, with a 24h change of +0.76%. Among 7 constituents, 7 are up (100.00%) and 0 are down (0%). The top gainer is GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK), with a 24h increase of +1.20%.CAR-T steady; breadth mixed. Favor leaders; be selective.
Name
Letzter Preis
Änderung %
Letzter Preis / Änderung %
Chart
Price Range
Aktion
JNJ
JNJJohnson & Johnson
266,01$270,00
+0,98 %
+1,49 %
AH
266,01
+0,98 %
$264,75$268,36
AMGN
AMGNAmgen Inc
376,09$378,35
+0,01 %
+0,60 %
AH
376,09
+0,01 %
$376,08$381,60
PFE
PFEPfizer Inc.
24,67$24,68
+0,48 %
+0,04 %
AH
24,67
+0,48 %
$24,62$24,84
GILD
GILDGilead Sciences Inc
130,49$130,58
+0,89 %
+0,06 %
AH
130,49
+0,89 %
$130,49$132,51
GSK
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)
51,97$51,98
+1,20 %
+0,01 %
AH
51,97
+1,20 %
$51,90$52,47
INCY
INCYIncyte Genomics Inc
118,93$118,90
+1,07 %
-0,02 %
AH
118,93
+1,07 %
$118,93$120,00
NVS
NVSNovartis AG
156,11$156,11
+0,71 %
0,00 %
AH
156,11
+0,71 %
$156,11$157,59